Related Experiment Video
Updated: Jul 6, 2026
05:38
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
Published on: January 7, 2019
Using the PDQ-39 in routine care for Parkinson's disease
Carolyn Neff1, Margaret C Wang2, Helene Martel2
1Southern California Permanente Medical Group, MOB2 Bldg 81154, 6650 Alton Parkway, Irvine, CA 92618 USA.
Parkinsonism & Related Disorders
|June 2, 2018
Summary
Routine use of the Parkinson's Disease Questionnaire (PDQ-39) in clinical practice helps identify patient concerns and improves communication. This quality improvement project shows the PDQ-39 is valuable for patients, caregivers, and providers.
Area of Science:
- Neurology
- Quality Improvement
- Patient-Reported Outcomes
Background:
- The 39-item Parkinson's Disease Questionnaire (PDQ-39) can identify patient-important symptoms in routine care.
- Evidence documenting its use in clinical practice is limited.
Purpose of the Study:
- To assess the feasibility and value of integrating the PDQ-39 into routine clinical care for Parkinson's disease patients.
- To evaluate the impact of PDQ-39 use on patient-provider communication and goal setting.
Main Methods:
- A quality improvement pilot project was conducted.
- Interviews were held with patients, caregivers, and healthcare providers.
- The PDQ-39 was integrated into clinic workflows for outpatient visits.
Main Results:
- PDQ-39 administration and scoring were successfully integrated into clinical workflows.
- Patients found the PDQ-39 helpful for guiding discussions and identifying quality of life factors.
- Caregivers gained insights into patients' daily needs, and providers found discussions more efficient.
Conclusions:
- The PDQ-39 can be effectively integrated into busy clinical practices.
- Routine use of the PDQ-39 provides significant value for patients, caregivers, and healthcare providers in managing Parkinson's disease.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:30Peritoneal Dialysis I: Introduction and Procedure
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
01:25Peritoneal Dialysis III: Nursing Management
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...